Trial Profile
Study of sofosbuvir/velpatasvir/ voxilaprevir in patients with cirrhosis in a French compassionate program
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 10 Jan 2020
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 13 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases